What does high direct bilirubin mean?

High direct bilirubin indicates your liver may have trouble processing or eliminating bilirubin, potentially signaling liver disease, bile duct obstruction, or other conditions. Testing and evaluation can help identify the underlying cause and guide appropriate treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Direct Bilirubin and Its Role in Your Body

Bilirubin is a yellow pigment produced when your body breaks down old red blood cells. This natural process happens continuously as red blood cells have a lifespan of about 120 days. When these cells break down, they release hemoglobin, which is converted into bilirubin in your spleen and bone marrow.

There are two main types of bilirubin in your blood: indirect (unconjugated) and direct (conjugated) bilirubin. Indirect bilirubin is the initial form that's not water-soluble and must be processed by the liver. Once in the liver, it's converted to direct bilirubin by binding with glucuronic acid, making it water-soluble and ready for elimination through bile.

Direct bilirubin normally makes up a small portion of your total bilirubin levels. When direct bilirubin levels are elevated, it typically indicates that your liver has successfully processed the bilirubin but is having trouble eliminating it through the bile ducts into your intestines. Understanding your bilirubin levels through comprehensive testing can provide valuable insights into your liver health and overall metabolic function.

Direct Bilirubin Reference Ranges and Clinical Significance

Direct bilirubin levels should always be interpreted alongside total bilirubin and other liver function tests for accurate diagnosis.
Direct Bilirubin LevelCategoryClinical SignificanceCommon Causes
0-0.3 mg/dL0-0.3 mg/dLNormalHealthy liver functionN/A - Normal finding
0.4-1.0 mg/dL0.4-1.0 mg/dLMildly ElevatedMay indicate early liver dysfunctionMedication effects, mild hepatitis, early obstruction
1.1-5.0 mg/dL1.1-5.0 mg/dLModerately ElevatedSignificant liver or bile duct problemHepatitis, partial bile duct obstruction, cirrhosis
>5.0 mg/dL>5.0 mg/dLSeverely ElevatedSerious condition requiring urgent evaluationComplete bile duct obstruction, severe hepatitis, liver failure

Direct bilirubin levels should always be interpreted alongside total bilirubin and other liver function tests for accurate diagnosis.

Normal vs. High Direct Bilirubin Levels

Understanding what constitutes normal and elevated direct bilirubin levels is crucial for interpreting your test results. Here's what you need to know about the reference ranges and their clinical significance.

Direct bilirubin levels above 0.3 mg/dL are generally considered elevated. However, the clinical significance depends on how high the levels are and whether other liver function tests are also abnormal. Mild elevations might not cause noticeable symptoms, while significant elevations can lead to jaundice and other health issues.

It's important to note that direct bilirubin should always be interpreted alongside total bilirubin and other liver function tests for a complete picture of your liver health. The ratio of direct to total bilirubin can also provide important diagnostic clues about the underlying cause of elevation.

Common Causes of High Direct Bilirubin

Liver Diseases and Conditions

Various liver conditions can impair the organ's ability to eliminate direct bilirubin effectively. Hepatitis, whether viral (hepatitis A, B, or C), alcoholic, or autoimmune, causes inflammation that can damage liver cells and bile ducts. This damage disrupts the normal flow of bile, leading to a backup of direct bilirubin in the bloodstream.

Cirrhosis, the advanced scarring of liver tissue, represents another major cause of elevated direct bilirubin. As healthy liver tissue is replaced by scar tissue, the liver's ability to process and eliminate bilirubin becomes severely compromised. Other liver conditions that can elevate direct bilirubin include:

  • Primary biliary cholangitis (PBC)
  • Primary sclerosing cholangitis (PSC)
  • Drug-induced liver injury
  • Fatty liver disease (NAFLD/NASH)
  • Liver cancer or metastases

Bile Duct Obstructions

Blockages in the bile ducts prevent direct bilirubin from flowing normally from the liver to the intestines. Gallstones are the most common cause, particularly when they migrate from the gallbladder into the common bile duct. These stones can completely or partially block bile flow, causing direct bilirubin to accumulate in the blood.

Other causes of bile duct obstruction include pancreatic tumors pressing on the bile duct, bile duct strictures (narrowing), and cholangiocarcinoma (bile duct cancer). Parasitic infections, though less common in developed countries, can also cause bile duct blockages.

Genetic and Metabolic Disorders

Several inherited conditions can affect bilirubin metabolism and lead to elevated direct bilirubin levels. Dubin-Johnson syndrome and Rotor syndrome are rare genetic disorders that impair the liver's ability to excrete conjugated bilirubin into bile. While these conditions cause chronic elevation of direct bilirubin, they're generally benign and don't lead to liver damage.

Other genetic conditions affecting bilirubin metabolism include progressive familial intrahepatic cholestasis (PFIC) and benign recurrent intrahepatic cholestasis (BRIC). These conditions can cause episodes of elevated direct bilirubin along with other symptoms like itching and fatigue.

Symptoms Associated with High Direct Bilirubin

The symptoms of elevated direct bilirubin can vary depending on the underlying cause and the severity of the elevation. Many people with mildly elevated levels may not experience any noticeable symptoms, while others with more significant elevations can develop various signs and symptoms.

Jaundice is the most recognizable symptom of high bilirubin levels. It causes a yellowing of the skin and the whites of the eyes (sclera). This yellowing typically becomes visible when total bilirubin levels exceed 2.5-3.0 mg/dL. The yellow color results from bilirubin accumulating in body tissues.

Other common symptoms associated with elevated direct bilirubin include:

  • Dark urine (tea or cola-colored) due to bilirubin excretion through kidneys
  • Pale or clay-colored stools from lack of bilirubin reaching the intestines
  • Intense itching (pruritus) without a rash
  • Fatigue and general weakness
  • Abdominal pain, particularly in the upper right quadrant
  • Nausea and loss of appetite
  • Unexplained weight loss
  • Fever (if infection is present)

The presence and severity of these symptoms often depend on how quickly the bilirubin levels rise and the underlying condition causing the elevation. Acute conditions like bile duct obstruction from gallstones may cause sudden, severe symptoms, while chronic liver diseases might lead to a gradual onset of symptoms.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Tests and Evaluation

When direct bilirubin levels are elevated, healthcare providers typically order a comprehensive metabolic panel and additional liver function tests to evaluate the underlying cause. These tests work together to provide a complete picture of liver health and help identify the specific condition causing the elevation. Regular monitoring of these biomarkers can help track treatment progress and overall liver function.

Blood Tests

A comprehensive liver panel typically includes measurements of both direct and total bilirubin, along with other important markers:

  • ALT (Alanine Aminotransferase) and AST (Aspartate Aminotransferase) - enzymes that indicate liver cell damage
  • Alkaline Phosphatase (ALP) - elevated in bile duct obstruction
  • GGT (Gamma-Glutamyl Transferase) - helps differentiate liver from bone disease when ALP is elevated
  • Albumin and total protein - assess liver's synthetic function
  • PT/INR (Prothrombin Time) - evaluates blood clotting function
  • Complete blood count (CBC) - checks for anemia or infection

Imaging Studies

When blood tests suggest elevated direct bilirubin, imaging studies help visualize the liver, gallbladder, and bile ducts to identify structural problems. Ultrasound is typically the first imaging test ordered because it's non-invasive and can effectively detect gallstones, bile duct dilation, and liver abnormalities.

More advanced imaging may include CT scans for detailed liver anatomy, MRCP (Magnetic Resonance Cholangiopancreatography) for excellent bile duct visualization, or ERCP (Endoscopic Retrograde Cholangiopancreatography), which can both diagnose and treat bile duct obstructions.

Treatment Options for High Direct Bilirubin

Treatment for elevated direct bilirubin focuses on addressing the underlying cause rather than the bilirubin level itself. The approach varies significantly depending on whether the cause is an obstruction, liver disease, or genetic condition. Here's an overview of treatment strategies based on different causes.

Medical Management

For liver diseases causing elevated direct bilirubin, treatment may include antiviral medications for hepatitis, immunosuppressants for autoimmune conditions, or ursodeoxycholic acid for certain cholestatic liver diseases. Lifestyle modifications, including alcohol cessation and weight management, play crucial roles in managing many liver conditions.

Symptomatic treatment is also important. Medications like cholestyramine can help relieve itching associated with cholestasis, while vitamin supplementation (particularly fat-soluble vitamins A, D, E, and K) may be necessary when bile flow is impaired.

Surgical and Procedural Interventions

Bile duct obstructions often require procedural intervention. ERCP can remove gallstones from the bile duct and place stents to maintain bile flow. For recurrent gallstone-related problems, cholecystectomy (gallbladder removal) may be recommended. In cases of tumors causing obstruction, surgery, chemotherapy, or radiation therapy might be necessary depending on the type and stage of cancer.

When to Seek Medical Attention

While mild elevations in direct bilirubin might not cause immediate symptoms, certain situations warrant prompt medical evaluation. You should contact your healthcare provider if you notice yellowing of your skin or eyes, dark urine persisting for several days, or pale stools accompanied by abdominal pain.

Seek immediate medical attention if you experience:

  • Severe abdominal pain, especially with fever
  • Confusion or changes in mental status
  • Persistent vomiting preventing fluid intake
  • Signs of bleeding (black stools, vomiting blood)
  • Severe fatigue with jaundice

These symptoms could indicate serious complications requiring urgent treatment, such as acute cholangitis (bile duct infection) or acute liver failure.

Prevention and Long-term Management

While not all causes of elevated direct bilirubin are preventable, many lifestyle factors can support liver health and reduce your risk of developing conditions that lead to high bilirubin levels. Maintaining a healthy weight, limiting alcohol consumption, and avoiding exposure to hepatotoxic substances are fundamental preventive measures.

Regular health screenings play a vital role in early detection and prevention. Routine liver function tests can identify problems before symptoms develop, allowing for earlier intervention and better outcomes. Vaccination against hepatitis A and B can prevent these viral infections that commonly cause liver damage.

For those with chronic liver conditions or genetic disorders affecting bilirubin metabolism, long-term management involves regular monitoring, medication compliance, and lifestyle modifications. Working closely with healthcare providers to develop a comprehensive management plan is essential for maintaining liver health and preventing complications.

Living with Elevated Direct Bilirubin

Managing elevated direct bilirubin levels requires understanding your specific condition and following your treatment plan carefully. Many people with chronic elevations due to genetic conditions like Dubin-Johnson syndrome lead normal, healthy lives with minimal intervention. However, those with liver disease or bile duct problems may need more intensive management and lifestyle adjustments.

Dietary modifications can support liver health and potentially improve bilirubin levels. A balanced diet rich in fruits, vegetables, whole grains, and lean proteins provides essential nutrients for liver function. Limiting processed foods, saturated fats, and added sugars can reduce the liver's workload and support overall metabolic health.

Regular exercise, stress management, and adequate sleep also contribute to liver health. These lifestyle factors work together to reduce inflammation, improve metabolism, and support your body's natural detoxification processes. Remember that managing elevated direct bilirubin is often a long-term process requiring patience and consistency in following medical advice and maintaining healthy habits.

References

  1. Fevery, J. (2008). Bilirubin in clinical practice: a review. Liver International, 28(5), 592-605.[PubMed][DOI]
  2. Vítek, L., & Ostrow, J. D. (2009). Bilirubin chemistry and metabolism; harmful and protective aspects. Current Pharmaceutical Design, 15(25), 2869-2883.[PubMed][DOI]
  3. European Association for the Study of the Liver. (2017). EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. Journal of Hepatology, 67(1), 145-172.[PubMed][DOI]
  4. Erlinger, S., Arias, I. M., & Dhumeaux, D. (2014). Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology, 146(7), 1625-1638.[PubMed][DOI]
  5. Sticova, E., & Jirsa, M. (2013). New insights in bilirubin metabolism and their clinical implications. World Journal of Gastroenterology, 19(38), 6398-6407.[PubMed][DOI]
  6. Kuntz, E., & Kuntz, H. D. (2008). Hepatology: Textbook and Atlas (3rd ed.). Springer-Verlag Berlin Heidelberg.[DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my direct bilirubin at home?

You can test your direct bilirubin at home with SiPhox Health's Heart & Metabolic Program, which includes direct bilirubin testing along with comprehensive liver function markers like ALT, AST, and total bilirubin. The program provides CLIA-certified lab results from the comfort of your home.

What is the difference between direct and indirect bilirubin?

Direct (conjugated) bilirubin is water-soluble and has been processed by the liver, ready for elimination through bile. Indirect (unconjugated) bilirubin is fat-soluble and hasn't yet been processed by the liver. High direct bilirubin typically indicates problems with bile flow or liver cell function, while high indirect bilirubin suggests increased red blood cell breakdown or liver processing issues.

Can high direct bilirubin levels return to normal?

Yes, direct bilirubin levels can often return to normal once the underlying cause is treated. For example, removing a gallstone blocking the bile duct or treating hepatitis can normalize levels. However, chronic conditions like cirrhosis may cause persistently elevated levels that require ongoing management.

What foods should I avoid with high direct bilirubin?

While diet alone won't cure elevated direct bilirubin, avoiding alcohol, fatty foods, and processed foods can reduce liver stress. Focus on a balanced diet with plenty of fruits, vegetables, whole grains, and lean proteins. Stay hydrated and limit foods high in saturated fats and added sugars.

Is elevated direct bilirubin always serious?

Not always. Some people have benign genetic conditions like Dubin-Johnson syndrome that cause chronic mild elevations without health consequences. However, new or sudden elevations should always be evaluated by a healthcare provider to rule out serious conditions like bile duct obstruction or liver disease.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details